Product image of Naratriptan Al (Naratriptan) supplied by GNH India

Naratriptan Al

Active Ingredient:
Naratriptan
Origin:
EU

Naratriptan Al (Naratriptan)

Naratriptan, the active ingredient in Naratriptan Al, is a Triptan (selective 5‑HT1B/1D receptor agonist) presented as an oral tablet for oral use. It is indicated for the acute treatment of migraine attacks in adult patients.

GNH India supplies Naratriptan Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Aliud Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Naratriptan is used in the management of migraine, a vascular headache disorder.

  • Migraine without aura: provides rapid relief of headache pain and associated symptoms during an acute attack.
  • Migraine with aura: reduces the severity of headache and associated nausea when taken at onset.
  • Acute migraine attacks: aborts the migraine episode and improves functional ability.

How It Works

  • Naratriptan acts as an agonist at serotonin 5‑HT1B and 5‑HT1D receptors located on intracranial blood vessels and trigeminal nerve endings. Activation of 5‑HT1B receptors induces cranial vasoconstriction, while stimulation of 5‑HT1D receptors inhibits release of pro‑inflammatory neuropeptides such as CGRP. The combined vascular and neurogenic effects alleviate migraine headache and associated symptoms.

Side Effects

Naratriptan may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Fatigue: feeling unusually tired or weak.
  • Dry mouth: reduced salivation causing throat discomfort.
  • Paresthesia: tingling or numbness in the extremities.

Serious or Rare Side Effects

  • Chest pain or tightness: may indicate coronary vasospasm.
  • Severe hypertension: sudden increase in blood pressure.
  • Serotonin syndrome: agitation, hyperthermia, muscle rigidity when combined with serotonergic agents.
  • Allergic reactions: rash, itching, swelling, or anaphylaxis.
  • Ischemic cardiac events: myocardial infarction or angina in susceptible individuals.

Precautions & Warnings

Before prescribing Naratriptan, consider the following precautions to ensure safe use.

  • Cardiovascular disease: evaluate risk of coronary artery disease before use.
  • History of stroke or transient ischemic attack: avoid due to potential cerebrovascular effects.
  • Concomitant serotonergic medications: monitor for signs of serotonin syndrome.
  • Pregnancy: safety not established; use only if benefit outweighs risk.
  • Elderly patients: start with the lowest effective dose and monitor closely.
  • Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture.

Avoid Interactions

Naratriptan can interact with other medicines; notable interactions are categorized by clinical significance.

Major Interactions (Avoid)

  • MAO inhibitors: risk of severe hypertension and serotonin syndrome.
  • SSRIs, SNRIs, or other serotonergic agents: may precipitate serotonin syndrome.
  • Ergot alkaloids: combined vasoconstriction can cause serious cardiovascular events.
  • Other triptans: additive vasoconstrictive effect increases risk of ischemia.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole): may increase naratriptan plasma levels.
  • CYP2D6 inhibitors (e.g., fluoxetine): may modestly raise exposure, requiring observation.

Frequently Asked Questions

Naratriptan Al is prescribed for the acute treatment of migraine attacks in adult patients. It helps to relieve headache pain, nausea, and sensitivity to light or sound when taken at the onset of a migraine episode.

Naratriptan works by binding to serotonin 5‑HT1B and 5‑HT1D receptors in the brain. This action causes constriction of dilated cranial blood vessels and blocks the release of inflammatory neuropeptides, thereby reducing migraine pain and associated symptoms.

The dose of Naratriptan Al is determined by the prescribing healthcare professional based on the patient’s medical history, severity of migraine, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Naratriptan in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and only under the guidance of a qualified healthcare provider.

To order Naratriptan Al, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Naratriptan is a second‑generation triptan with a longer half‑life than sumatriptan, which may provide sustained relief for prolonged migraine attacks. Both share a similar mechanism of 5‑HT1B/1D agonism, but individual response and side‑effect profiles can differ, so clinicians choose based on patient tolerance and attack characteristics.

Naratriptan Al should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Naratriptan Al is administered orally as a tablet. The tablet should be swallowed whole with a glass of water, preferably at the first sign of a migraine attack. Patients should not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.

Serious risks include chest pain or tightness, severe hypertension, serotonin syndrome when combined with other serotonergic drugs, and rare allergic reactions such as anaphylaxis. Patients experiencing any of these symptoms should seek immediate medical attention.

Naratriptan Al should be avoided in patients with uncontrolled cardiovascular disease, a history of myocardial infarction, stroke, or transient ischemic attack, and in those taking MAO inhibitors or other triptans. It is also contraindicated in individuals with known hypersensitivity to naratriptan or any of its excipients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Naratriptan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT